Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.9 HKD | +5.62% | -2.27% | -17.04% |
09/05 | Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director | CI |
22/03 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.04% | 44Cr | |
+8.38% | 13TCr | |
-6.68% | 1.1TCr | |
+1.56% | 897.32Cr | |
+36.32% | 556.05Cr | |
-21.55% | 498.64Cr | |
+8.20% | 344.02Cr | |
-7.69% | 280.12Cr | |
-8.42% | 217.7Cr | |
-5.20% | 216.16Cr |
- Stock Market
- Equities
- 2190 Stock
- News Zylox-Tonbridge Medical Technology Co., Ltd.
- Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device